Global AI in Omics Studies Market, By Offering (Software, Services), By Technology Platform (Sequencing, Epigenomics, Proteomics, Metabolomics, thers), By Application (Oncology, Infectious Diseases, Neurology, Cardiovascular Diseases, Immunology, Others), By End User (Academic and Research Institutes, Biopharmaceutical Company, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Dec 2023

Code : CMI6516

Pages :172

Formats :

Excel and PDF

Industry : Healthcare IT

Market News

Global AI in Omics Studies Market- Recent Developments

Product and Technology Launch

On September 20, 2023, DNAstack, a software company, launched Omics AI, a revolutionary new software suite for omics and health research. Omics AI makes scientific discoveries faster and more powerful by enabling insights across federated networks of data in compliance with open standards provided by the Global Alliance for Genomics & Health (GA4GH). The system is being used by world leading pharmaceutical companies, hospitals, universities, patient advocacy groups, funders, sequencing facilities, government agencies, and consortiums to grow collaborative networks in diverse areas of research.
On April 14, 2023, Bimodal, a biotechnology company, launched its new duet multiomics solution, which it says reveals the combinatorial power of genetic and epigenetic information from a single low-volume sample. The duet multiomics solution is the world’s first single-base-resolution sequencing technology that enables the simultaneous phased reading of genetic and epigenetic information in a single sample with one workflow using any sequencer.
In November 2022, Amazon Web Services, Inc., a cloud computing company, launched Amazon Omics for precision medicine. Amazon omics is a cloud-based platform that provides security, scale, and the processing power needed for genomic data storage and analysis, eliminating the need for specialized infrastructure and workflows.

Acquisition and Collaboration

On November 6, 2023, OWKIN, a biotechnology company and 10x Genomics, Inc., a biotechnology company, announced they have entered into an agreement to add 10x Genomics spatial omics and single-cell technologies to work in tumor analysis for therapeutic discovery.
On September 4, 2023, Intelligent OMICS Ltd, a biotechnology company, has agreed an AI-driven research collaboration with Janssen Global Services, LLC, pharmaceutical company, The collaboration with Janssen Global Services, LLC, is evaluate novel biological targets for the treatment of haematological cancers.

Global AI in Omics Studies Market- Recent Developments

Product and Technology Launch